Fasturtec - direct healthcare professional communication (DHPC)

rasburicase

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communications (DHPC) : Supply shortage of Fasturtec (rasburicase) 7.5 mg/5 ml powder and solvent for concentrate for solution for infusion (EU/1/00/170/002)

Dissemination date: 17/02/2023

Key facts

• Medicine name:
  Fasturtec
• Active substance:
  rasburicase
• Therapeutic area (MeSH):
  Hyperuricemia
• Procedure number:
  EMEA/H/C/000331
• DHPC type:
  Medicine shortage
• Human ATC codes:
  V03AF07
• Dissemination date:
  17/02/2023